The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge panel from that court found those laws to be unconstitutional. At the time of those decisions, AHA General Counsel Chad Golder stated, they “scream out for rehearing by the full Fourth Circuit. As the dissenting judge correctly points out, the majority rests its decision on arguments that the parties never made. It invents new theories of preemption that lack any basis in the law. It conflicts with the decisions of courts across the country. And it is wrong. We look forward to it being overturned.”  

The full court of appeals will now reconsider those decisions. Two federal courts of appeals have upheld similar laws in Louisiana and Arkansas. The AHA filed amicus briefs in support of the West Virginia and Maryland laws in both the district court and the 4th Circuit. 

Headline
The Wall Street Journal today published a letter to the editor from AHA General Counsel Chad Golder responding to a May 7 editorial criticizing the 340B Drug…
Headline
The AHA today urged Eli Lilly to abandon its 340B Drug Pricing Program claims-data policy and work with the AHA to develop a functional third-party…
Headline
The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that they could lose access to…
Headline
The Washington Post yesterday published a letter to the editor from AHA President and CEO Rick Pollack responding to an April 18 editorial criticizing the 340B…
Headline
The Health Resources and Services Administration should abandon its consideration of a 340B rebate model pilot program because “a rebate mechanism of any kind…
Headline
The AHA and others April 17 filed an amicus brief requesting the U.S. Court of Appeals for the 4th Circuit grant en banc review of a panel decision that…